/, Interstitial Cystitis Network Blog, Research/Lipella Study Seeks Men & Women With IC/BPS

Lipella Study Seeks Men & Women With IC/BPS

If you have been diagnosed with Interstitial Cystitis/ Bladder Pain Syndrome (IC/BPS) you may be eligible to participate in a new clinical research study to evaluate the safety and efficacy of an investigational drug made out of natural egg yolk (LP-08).  Lipella Pharmaceuticals, Inc. is conducting the study at Beaumont Hospital in Royal Oak, MI.

LP-08, a liposome product, has been studied in a previous clinical research study in the United States. This study includes an “open label extension.” This means that all patients that receive the placebo will be offered the investigational drug according to the study protocol.

The study is seeking 36 men and women age 18 or over. You must have had IC/BPS for a minimum of six months and have been diagnosed by a health care provider. You must be available to attend seven required clinic visits over approximately 12 weeks, including cystoscopies. If you choose to enter the “open label extension” your participation would extend another 12 weeks. Compensation for time/travel is available.

Interested in learning more? Please call 248-551-3355.

Disclosure:

Dr. Michael Chancellor, the Director of Neurourology at William Beaumont Hospital, developed LP-08, the drug being tested.  Dr. Chancellor will not be involved with conducting the study at William Beaumont Hospital but will benefit financially if the drug is approved for use by the Food and Drug Administration (FDA).

 

By |2015-11-20T11:46:02+00:00November 20th, 2015|Clinical Trials, Interstitial Cystitis Network Blog, Research|Comments Off on Lipella Study Seeks Men & Women With IC/BPS

About the Author:

My Google Profile+ Jill Heidi Osborne is the president and founder of the Interstitial Cystitis Network, a health education company dedicated to interstitial cystitis, bladder pain syndrome and other pelvic pain disorders. As the editor and lead author of the ICN and the IC Optimist magazine, Jill is proud of the academic recognition that her website has achieved. The University of London rated the ICN as the top IC website for accuracy, credibility, readability and quality. (Int Urogynecol J - April 2013). Harvard Medical School rated both Medscape and the ICN as the top two websites dedicated to IC. (Urology - Sept 11). Jill currently serves on the Congressionally Directed Medical Research Panel (US Army) where she collaborates with researchers to evaluate new IC research studies for possible funding. Jill has conducted and/or collaborates on a variety of IC research studies on new therapeutics, pain care, sexuality, the use of medical marijuana, menopause and the cost of treatments, shining a light on issues that influence patient quality of life. An IC support group leader and national spokesperson for the past 20 years, she has represented the IC community on radio, TV shows, at medical conferences. She has written hundreds of articles on IC and its related conditions. With a Bachelors Degree in Pharmacology and a Masters in Psychology, Jill was named Presidential Management Intern (aka Fellowship) while in graduate school. (She was unable to earn her PhD due to the onset of her IC.) She spends the majority of her time providing WELLNESS COACHING for patients in need and developing new, internet based educational and support tools for IC patients, including the “Living with IC” video series currently on YouTube and the ICN Food List smartphone app! Jill was diagnosed with IC at the age of 32 but first showed symptoms at the age of 12.